Pacific Biosciences Of California PACB
NASDAQ PACB
$2.23 -0.13 (-5.30%)
As of: Nov 10, 2026 · 1:35 PM EST

Pacific Biosciences Of California (PACB) Restructuring Costs (2021 - 2023)

Updated

Pacific Biosciences Of California (PACB) recorded Restructuring Costs of $63,000 in Q4 2023, down 99.3% from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) Restructuring Costs (2021 - 2023) Analysis & Trends

For FY2023, Pacific Biosciences Of California reported Restructuring Costs of $9.04 million.

  • Across earlier years, Restructuring Costs came in at $31.13 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn
10 Pacific Biosciences Of California 703.42 Mn -288.34 Mn 13.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 63,000.00
Sep 30, 2023 8.98 Mn
Dec 31, 2021 403,000.00
Sep 30, 2021 30.73 Mn
API Access

Pacific Biosciences Of California Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PACB&period=max&api_key=YOUR_API_KEY